Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients With Melanoma and Lung Cancer Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients With Melanoma and Lung Cancer Brain Metastases: Initial Experiences
J. Nucl. Med. 2020 Sep 04;[EPub Ahead of Print], N Galldiks, DS Abdulla, M Scheffler, F Wolpert, JM Werner, MW Huellner, G Stoffels, V Schweinsberg, M Schlaak, N Kreuzberg, J Landsberg, P Lohmann, G Ceccon, C Baues, M Trommer, E Celik, MI Ruge, M Kocher, S Marnitz, GR Fink, JC Tonn, M Weller, KJ Langen, J Wolf, C MauchFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.